NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
13,66 € ↑0,85 (6,63%)
2026-06-04
CENA AKCJI
SecurityDE:038 / NovoCure Limited
InstitutionCitigroup Inc
Latest Disclosed Ownership137,010 shares
Latest Disclosed Value $ 1,493,409
Citigroup Inc ownership in 038 / NovoCure Limited

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 137,010 shares of NovoCure Limited (DE:038) valued at $1,207,058 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 206,819 shares of NovoCure Limited. This represents a change in shares of -33.75% during the quarter. The current value of the position is $1,872,242 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (038) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:038 / NovoCure Limited Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVOCURE ORD SHS G6674U108 137,010 -69,809 -33.75 1,493 -44.17 0.0003
2026-02-13 2025-12-31 13F NOVOCURE ORD SHS G6674U108 206,819 142,886 223.49 2,674 223.73 0.0012
2025-11-10 2025-09-30 13F NOVOCURE ORD SHS G6674U108 63,933 -641,713 -90.94 826 -93.42 0.0004
2025-08-11 2025-06-30 13F NOVOCURE ORD SHS G6674U108 705,646 620,947 733.12 12,560 732.34 0.0062
2025-05-12 2025-03-31 13F NOVOCURE ORD SHS G6674U108 84,699 -9,270 -9.86 1,509 -46.11 0.0008
2025-02-12 2024-12-31 13F NOVOCURE ORD SHS G6674U108 93,969 11,361 13.75 2,800 116.89 0.0017
2024-11-12 2024-09-30 13F NOVOCURE ORD SHS G6674U108 82,608 -41,229 -33.29 1,291 -39.13 0.0007
2024-08-12 2024-06-30 13F NOVOCURE ORD SHS G6674U108 123,837 12,721 11.45 2,121 22.18 0.0014
2024-05-10 2024-03-31 13F NOVOCURE ORD SHS G6674U108 111,116 -132,519 -54.39 1,737 -52.27 0.0011
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS G6674U108 243,635 200,363 463.03 3,637 421.06 0.0026
2023-12-06 2023-09-30 13F/A-1 NOVOCURE ORD SHS G6674U108 43,272 -43,563 -50.17 699 -80.63 0.0005
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS G6674U108 43,272 -43,563 699 0.0005
2023-08-10 2023-06-30 13F NOVOCURE ORD SHS G6674U108 86,835 -12,000 -12.14 3,604 -39.37 0.0024
2023-05-11 2023-03-31 13F NOVOCURE ORD SHS G6674U108 98,835 -4,167 -4.05 5,944 -21.34 0.0042
2023-02-09 2022-12-31 13F NOVOCURE ORD SHS G6674U108 103,002 16,905 19.63 7,555 15.50 0.0060
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS G6674U108 86,097 5,259 6.51 6,541 16.41 0.0047
2022-08-10 2022-06-30 13F NOVOCURE ORD SHS G6674U108 80,838 -1,316 -1.60 5,619 -17.45 0.0042
2022-05-12 2022-03-31 13F NOVOCURE ORD SHS G6674U108 82,154 -66,411 -44.70 6,807 -38.97 0.0041
2022-02-10 2021-12-31 13F NOVOCURE ORD SHS G6674U108 148,565 35,806 31.75 11,154 -14.85 0.0060
2021-11-10 2021-09-30 13F NOVOCURE ORD SHS G6674U108 112,759 19,480 20.88 13,099 -36.69 0.0077
2021-08-10 2021-06-30 13F NOVOCURE ORD SHS G6674U108 93,279 10,647 12.88 20,691 89.43 0.0125
2021-05-13 2021-03-31 13F NOVOCURE ORD SHS G6674U108 82,632 -54,753 -39.85 10,923 -54.05 0.0071
2021-02-11 2020-12-31 13F NOVOCURE ORD SHS G6674U108 137,385 73,841 116.20 23,773 236.06 0.0140
2020-11-12 2020-09-30 13F NOVOCURE ORD SHS G6674U108 63,544 24,633 63.31 7,074 206.63 0.0046
2020-08-12 2020-06-30 13F NOVOCURE ORD SHS G6674U108 38,911 -50,903 -56.68 2,307 -61.86 0.0018
2020-05-12 2020-03-31 13F NOVOCURE ORD SHS G6674U108 89,814 58,662 188.31 6,048 130.40 0.0055
2020-02-12 2019-12-31 13F NOVOCURE ORD SHS G6674U108 31,152 -35,620 -53.35 2,625 -47.43 0.0019
2019-11-08 2019-09-30 13F NOVOCURE ORD SHS G6674U108 66,772 29,274 78.07 4,993 110.59 0.0040
2019-08-12 2019-06-30 13F NOVOCURE ORD SHS G6674U108 37,498 21,180 129.80 2,371 201.65 0.0019
2019-05-13 2019-03-31 13F NOVOCURE ORD SHS G6674U108 16,318 989 6.45 786 53.22 0.0008
2019-02-12 2018-12-31 13F NOVOCURE ORD SHS G6674U108 15,329 7,045 85.04 513 18.20 0.0005
2018-11-13 2018-09-30 13F NOVOCURE ORD SHS G6674U108 8,284 -174 -2.06 434 63.77 0.0004
2018-08-10 2018-06-30 13F NOVOCURE ORD SHS G6674U108 8,458 8,156 2,700.66 265 3,685.71 0.0002
2018-05-11 2018-03-31 13F NOVOCURE ORD SHS G6674U108 302 -8,227 -96.46 7 -95.93 0.0000
2018-02-12 2017-12-31 13F NOVOCURE ORD SHS G6674U108 8,529 7,949 1,370.52 172 1,333.33 0.0001
2017-11-13 2017-09-30 13F NOVOCURE ORD SHS G6674U108 580 35 6.42 12 33.33 0.0000
2017-08-11 2017-06-30 13F NOVOCURE ORD SHS G6674U108 545 -7,112 -92.88 9 -85.48 0.0000
2017-05-12 2017-03-31 13F NOVOCURE ORD SHS G6674U108 7,657 -49,181 -86.53 62 -86.10 0.0001
2017-02-10 2016-12-31 13F NOVOCURE ORD SHS G6674U108 56,838 51,403 945.78 446 848.94 0.0004
2016-11-10 2016-09-30 13F NOVOCURE ORD SHS G6674U108 5,435 2,011 58.73 47 17.50 0.0000
2016-08-12 2016-06-30 13F NOVOCURE ORD SHS G6674U108 3,424 -3,560 -50.97 40 -60.40 0.0000
2016-05-13 2016-03-31 13F NOVOCURE ORD SHS G6674U108 6,984 4,434 173.88 101 77.19 0.0001
2016-02-12 2015-12-31 13F NOVOCURE ORD SHS G6674U108 2,550 2,550 57 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-12-06 2023-09-30 13F/A NOVOCURE ORD SHS Call 50,000 -89.56 808 -95.94 n/a n/a n/a
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS Call 50,000 808 n/a n/a n/a
2023-08-10 2023-06-30 13F NOVOCURE ORD SHS Call 479,000 2.46 19,878 -29.30 n/a n/a n/a
2023-05-11 2023-03-31 13F NOVOCURE ORD SHS Call 467,500 28,115 n/a n/a n/a
2022-05-12 2022-03-31 13F NOVOCURE ORD SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F NOVOCURE ORD SHS Call 115,200 8,649 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-05-10 2024-03-31 13F NOVOCURE ORD SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-09 2023-12-31 13F NOVOCURE ORD SHS Put 75,900 0.00 1,133 -7.51 n/a n/a n/a
2023-12-06 2023-09-30 13F/A NOVOCURE ORD SHS Put 75,900 0.00 1,226 -61.10 n/a n/a n/a
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS Put 75,900 1,226 n/a n/a n/a
2023-08-10 2023-06-30 13F NOVOCURE ORD SHS Put 75,900 1,085.94 3,150 720.05 n/a n/a n/a
2023-05-11 2023-03-31 13F NOVOCURE ORD SHS Put 6,400 -95.91 385 -96.65 n/a n/a n/a
2023-02-09 2022-12-31 13F NOVOCURE ORD SHS Put 156,400 -21.80 11,472 -24.51 n/a n/a n/a
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS Put 200,000 33.33 15,196 45.76 n/a n/a n/a
2022-08-10 2022-06-30 13F NOVOCURE ORD SHS Put 150,000 0.00 10,425 -16.12 n/a n/a n/a
2022-05-12 2022-03-31 13F NOVOCURE ORD SHS Put 150,000 -60.53 12,428 -56.44 n/a n/a n/a
2022-02-10 2021-12-31 13F NOVOCURE ORD SHS Put 380,000 1.33 28,530 -34.51 n/a n/a n/a
2021-11-10 2021-09-30 13F NOVOCURE ORD SHS Put 375,000 7.14 43,564 -43.89 n/a n/a n/a
2021-08-10 2021-06-30 13F NOVOCURE ORD SHS Put 350,000 77,637 n/a n/a n/a
2018-02-12 2017-12-31 13F NOVOCURE ORD SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-13 2017-09-30 13F NOVOCURE ORD SHS Put 11,500 228 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.